📈 Jumpstart Signal Watchlist — September 22, 2026

🏢 What they do: Vir Biotechnology is a clinical-stage biopharmaceutical company that develops medicines for serious infectious diseases and cancer. Its work centers on immune-based therapies, including antibody-based and other platform-driven drug candidates such as programs for hepatitis delta, hepatitis B, and solid tumors.
- 🎯 Current $11.50 is 9% below 3yr high $12.66 · ⏳ SMA200 $8.78 (current price $11.50 is above) · 💰 Market Cap $1.9B
- VIR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 32/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 159% (>20%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.6%)
- 🔔 Strong above EMA50 (12.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Vir Biotechnology stock hits 52-week high at 11.66 USD — Investing.com.
🤖 Vir shares reached a 52-week high following strong second-quarter results, including $80.1 million in net income and approximately $1.01 billion in cash, cash equivalents, and investments. The article also noted H.C. Wainwright's reiterated Buy rating and the expected late-2026 and early-2027 data releases for the company's Phase 3 hepatitis D programs.
✅ Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Brokerages — MarketBeat.
🤖 Eight analysts collectively assign Vir a Moderate Buy consensus, with six Buy ratings and one Strong Buy versus one Sell. The $21.57 average price target implies substantial upside from the reported share price.
✅ Vir Biotechnology (NASDAQ:VIR) Sets New 52-Week High — MarketBeat.
🤖 Vir set a new 52-week high amid a generally favorable analyst outlook. The article cited a Moderate Buy consensus and a $21.57 average price target, although ratings include a Sell recommendation.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Five9, Inc. provides cloud contact center software, including its Intelligent CX platform for managing customer interactions across voice and digital channels like chat, email, SMS, and social media. Its products also include AI, automation, analytics, and workforce optimization tools that help businesses run customer service and sales operations.
- 🎯 Current $38.65 is 55% below 3yr high $85.47 · ⏳ SMA200 $22.01 (current price $38.65 is above) · 💰 Market Cap $2.9B
- FIVN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 45/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 300% (>20%); Low LT D/E 0.25 (<1.0); PEG ratio 0.19 (<1.5).
⏰ Entry (E): 7/20
- 🔔 Strong above EMA21 (16.0%)
- 🔔 Strong above EMA50 (25.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 68 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Five9, Inc. (FIVN) Hits Fresh High: Is There Still Room to Run? — Yahoo Finance.
🤖 Five9 shares reached a new 52-week high of $37.13 and were up 12.9% over the previous month, indicating strong recent market momentum.
✅ Cantor Fitzgerald Boosts Five9 (NASDAQ:FIVN) Price Target to $40.00 — MarketBeat.
🤖 Cantor Fitzgerald raised its price target from $34 to $40 while maintaining an Overweight rating. The article also cited quarterly adjusted EPS and revenue that exceeded consensus estimates.
⚪️ Five9 dips 6% after five-session winning streak (FIVN:NASDAQ) — Seeking Alpha.
🤖 Shares fell nearly 6% after rising more than 13% over the prior five sessions, appearing to reflect a pullback after a strong advance rather than a newly reported company-specific deterioration.
🍭 Bonus (B): 10/10 — Computer Processing & Data Prep (Technology sector)

🏢 What they do: Magnite is an advertising technology company that provides a sell-side platform for digital advertising. Its software helps publishers and media owners manage and monetize ad inventory across channels like connected TV, video, mobile, and desktop, while also connecting them with advertisers and agencies.
- 🎯 Current $24.80 is 6% below 3yr high $26.52 · ⏳ SMA200 $16.52 (current price $24.80 is above) · 💰 Market Cap $3.6B
- MGNI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 62% (>20%); ROE 18% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA50 (10.0%)
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×2; showing 4 of 5).
✅ B. Riley Financial Increases Magnite (NASDAQ:MGNI) Price Target to $30.00 — MarketBeat.
🤖 B. Riley raised its price target to $30 from $27 and maintained a Buy rating, implying upside from the then-current price. The article also cited Magnite's better-than-expected quarterly EPS and revenue.
✅ Magnite Gets Price-Target Hikes After Google Ad-Tech Ruling — Why Analysts See A Win For Independent Ad Tech — Yahoo Finance.
🤖 StoneX raised its target to $43 while retaining a Buy rating, and Craig-Hallum raised its target to $32 after the Google ad-tech remedies ruling. Analysts viewed expanded interoperability and auction-access requirements as favorable for independent ad-tech platforms such as Magnite.
⚪️ Magnite Promotes Brian Gephart to Chief Financial Officer — GlobeNewswire.
🤖 Magnite promoted its chief accounting officer, Brian Gephart, to CFO effective October 1, succeeding retiring CFO David Day. The planned leadership transition provides operational continuity but does not itself disclose a financial catalyst.
⚪️ Magnite (NASDAQ:MGNI) Director Sells $981,216.36 in Stock — MarketBeat.
🤖 The article reports a director's pre-arranged Rule 10b5-1 share sale. Routine insider-trading disclosures are not treated as a directional operating catalyst; the piece also recaps prior earnings strength and favorable analyst coverage.
🍭 Bonus (B): 10/10 — Computer Programming & Data Processing (Technology sector)

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 Current $61.03 is 2% below 3yr high $62.09 · ⏳ SMA200 $35.06 (current price $61.03 is above) · 💰 Market Cap $81.1B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 48/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 405% (>20%); Revenue growth 34% (>15%); Low LT D/E 0.82 (<1.0); PEG ratio 0.08 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.3%)
- 🔔 Strong above EMA50 (14.8%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×4 ❌×1; showing 3 of 5).
✅ Hewlett Packard Enterprise (HPE) Trading Up 1.6% - Still a Buy? — MarketBeat.
🤖 HPE shares rose 1.6%, while the company’s recent earnings beat analyst expectations and management provided fiscal 2026 guidance. Analysts maintained a generally positive outlook, with a Moderate Buy consensus rating.
✅ Hewlett Packard Enterprise (HPE) Wins Top Zacks Rank, Is It Still Undervalued? — Yahoo Finance.
🤖 HPE received a top Zacks Rank after earnings estimates were raised, reflecting improving analyst expectations. Although the stock had softened recently, its strong recent performance and estimate revisions were favorable catalysts.
❌ Hewlett Packard Enterprise Sinks 9% on Downgrade After Triple-Digit Run; Dell Falls 5%, Super Micro Drops 8% — Yahoo Finance.
🤖 HPE fell 9% after a Wall Street downgrade following a major year-to-date rally. The downgrade represents a valuation-related negative catalyst, even though the article also cited strong recent earnings and raised guidance.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $34.88 is 4% below 3yr high $36.37 · ⏳ SMA200 $25.95 (current price $34.88 is above) · 💰 Market Cap $4.4B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (6.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 46% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 📈 RSI at 53 in healthy mid-range
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Concentra Group Holdings Parent (CON) Beats Again And Expands ... — Yahoo Finance.
🤖 The article highlights another earnings beat, a new occupational health center in Daytona Beach, and continued share-price strength. It also notes the stock remains below a referenced fair-value estimate, suggesting additional potential upside.
✅ Beneficiary Of Increased Injuries From Data Center Capex (CON) — Seeking Alpha.
🤖 The article rates CON a Buy and cites a second-quarter earnings beat, 10% year-over-year revenue growth, 22.5% adjusted EBITDA growth, market-share gains, potential reimbursement increases, and an M&A pipeline. Its valuation discount and deleveraging are presented as supporting further upside.
✅ Concentra Group Holdings Parent Inc stock hits all-time high at 35.94 USD — Investing.com.
🤖 The article reports an all-time high alongside strong second-quarter results, including $606 million in revenue and $0.52 adjusted EPS, as well as a raised full-year outlook. It also cites an S&P Global Ratings upgrade and lower leverage, reinforcing the favorable outlook.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: Amphenol Corporation designs and manufactures electrical, electronic, and fiber-optic connectors, sensors, and interconnect systems. Its products are used in markets including aerospace, defense, automotive, information technology, telecommunications, industrial equipment, and medical devices.
- 🎯 Current $82.84 is 4% below 3yr high $86.49 · ⏳ SMA200 $72.11 (current price $82.84 is above) · 💰 Market Cap $101.6B
- APH shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 59% (>20%); Revenue growth 55% (>15%); ROE 33% (>15%); Low LT D/E 0.21 (<1.0).
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×4 ❌×1; showing 3 of 5).
✅ Wall Street Analysts Believe Amphenol (APH) Could Rally 27.8%: Here's is How to Trade — Zacks.
🤖 The article says the mean target from 16 short-term analyst estimates was $100.16, implying 27.8% upside from the referenced share price. The range of estimates was also entirely above that price, signaling favorable analyst expectations.
✅ APH's AI Datacom Strength Grows: Can It Challenge TEL & MRVL? — Zacks.
🤖 Amphenol's IT datacom sales rose 89% year over year in Q2, supported by AI-related demand, while CommScope contributed $1.2 billion of quarterly sales. The article notes rising earnings estimates, although it also flags a premium valuation.
❌ Amphenol (NYSE:APH) Given New $90.00 Price Target at TD Cowen — MarketBeat.
🤖 TD Cowen reduced its price target to $90 from $175 and maintained a Hold rating, a negative revision despite the new target still indicating modest upside from the referenced price. The article also notes Amphenol's strong quarterly earnings and revenue growth, which moderates the negative read-through.
🍭 Bonus (B): 0/10 — Electronic Connectors